Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities

v3.19.2
Accrued Expenses And Other Current Liabilities
6 Months Ended
Jun. 30, 2019
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Expenses and Other Current Liabilities
7. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities as of June 30, 2019 and December 31, 2018 consisted of the following: 
 
 
As of
 
 
June 30, 2019
 
December 31, 2018
Sales returns and allowances
 
$
4,579,975

 
$
3,972,510

Medicaid rebates
 
2,658,184

 
2,237,269

Minimum sales commitments, royalties payable, and purchase obligations
 
2,154,613

 
9,662,901

Compensation and benefits
 
1,974,655

 
1,953,065

Research and development expenses
 
1,132,456

 
278,132

Sales and marketing
 
627,025

 
1,112,378

General and administrative
 
182,835

 
235,721

Other
 
37,998

 
279,397

Total accrued expenses and other current liabilities
 
$
13,347,741

 
$
19,731,373